Functional characterization of tlmK unveiling unstable carbinolamide intermediates in the tallysomycin biosynthetic pathway.
Tallysomycins (TLMs) belong to the bleomycin family of anticancer antibiotics. TLMs differ from bleomycins primarily by the presence of a 4-amino-4,6-dideoxy-l-talose sugar attached to C-41 as part of a glycosylcarbinolamide. We previously proposed, on the basis of bioinformatics analysis of the tlm biosynthetic gene cluster from Streptoalloteichus hindustanus E465-94 ATCC 31158, that the tlmK gene is responsible for the attachment of this sugar moiety. We now report that inactivation of tlmK in S. hindustanus abolished TLM A and TLM B production, the resultant DeltatlmK mutant instead accumulated five new metabolites, and introduction of a functional copy of tlmK to the DeltatlmK mutant restored TLM A and TLM B production. Two major metabolites, TLM K-1 and TLM K-2, together with three minor metabolites, TLM K-3, TLM K-4, and TLM K-5, were isolated from the DeltatlmK mutant, and their structures were elucidated. These findings provide experimental evidence supporting the previous functional assignment of tlmK to encode a glycosyltransferase and unveil two carbinolamide pseudoaglycones as key intermediates in the TLM biosynthetic pathway. TlmK stabilizes the carbinolamide intermediates by glycosylating their hemiaminal hydroxyl groups, thereby protecting them from hydrolysis during TLM biosynthesis. In the absence of TlmK, the carbinolamide intermediates fragment to produce an amide TLM K-1 and aldehyde intermediates, which undergo further oxidative fragmentation to afford carboxylic acids TLM K-2, TLM K-3, TLM K-4, and TLM K-5.
Wang
Liyan
L
Division of Pharmaceutical Sciences, Department of Chemistry, and University of Wisconsin National Cooperative Drug Discovery Group, University of Wisconsin, Madison, Wisconsin 53705-2222, USA.
Tao
Meifeng
M
Wendt-Pienkoski
Evelyn
E
Galm
Ute
U
Coughlin
Jane M
JM
Shen
Ben
B
D000192:Actinomycetales / Q000201:enzymology* / Q000235:genetics; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D001761:Bleomycin / Q000031:analogs & derivatives* / Q000096:biosynthesis; D017353:Gene Deletion; D005798:Genes, Bacterial / Q000502:physiology*; D005964:Glucosyltransferases / Q000235:genetics / Q000378:metabolism*; D005810:Multigene Family / Q000502:physiology*
D000903:Antibiotics, Antineoplastic; D001426:Bacterial Proteins; D001761:Bleomycin; D005964:Glucosyltransferases; C016126:talisomycin